- Home
- CVBF vs HCM Comparison
CVBF vs HCM Comparison
Compare CVBF & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVBF
- HCM
- Stock Information
- Founded
- CVBF 1974
- HCM 2000
- Country
- CVBF United States
- HCM Hong Kong
- Employees
- CVBF N/A
- HCM N/A
- Industry
- CVBF Major Banks
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- CVBF Finance
- HCM Health Care
- Exchange
- CVBF Nasdaq
- HCM Nasdaq
- Market Cap
- CVBF 2.6B
- HCM 2.6B
- IPO Year
- CVBF N/A
- HCM N/A
- Fundamental
- Price
- CVBF $18.52
- HCM $14.99
- Analyst Decision
- CVBF Hold
- HCM Hold
- Analyst Count
- CVBF 6
- HCM 1
- Target Price
- CVBF $22.20
- HCM $19.00
- AVG Volume (30 Days)
- CVBF 840.5K
- HCM 85.0K
- Earning Date
- CVBF 04-23-2025
- HCM 03-19-2025
- Dividend Yield
- CVBF 4.33%
- HCM N/A
- EPS Growth
- CVBF N/A
- HCM N/A
- EPS
- CVBF 1.44
- HCM 0.04
- Revenue
- CVBF $504,821,000.00
- HCM $630,201,000.00
- Revenue This Year
- CVBF N/A
- HCM $28.98
- Revenue Next Year
- CVBF $6.87
- HCM $20.41
- P/E Ratio
- CVBF $12.82
- HCM $69.52
- Revenue Growth
- CVBF N/A
- HCM N/A
- 52 Week Low
- CVBF $15.71
- HCM $12.84
- 52 Week High
- CVBF $24.58
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- CVBF 37.24
- HCM 47.89
- Support Level
- CVBF $18.40
- HCM $14.00
- Resistance Level
- CVBF $19.26
- HCM $15.57
- Average True Range (ATR)
- CVBF 0.39
- HCM 0.47
- MACD
- CVBF 0.03
- HCM -0.11
- Stochastic Oscillator
- CVBF 29.81
- HCM 37.12
About CVBF CVB Financial Corporation
CVB Financial Corp is the holding company for Citizens Business Bank. Citizens Business Bank offers banking, lending, and investing services. It provides a full complement of lending products, including commercial, agribusiness, consumer, SBA, real estate, and construction loans, as well as equipment and vehicle leasing. Commercial products include lines of credit and other working capital financing, accounts receivable lending and letters of credit.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.